New injection for lung and skin conditions passes first safety check
NCT ID NCT05803902
First seen Jan 05, 2026 · Last updated Apr 30, 2026 · Updated 23 times
Summary
This early-stage study tested a new injection called 9MW1911 in 48 healthy adults to see if it is safe and how the body processes it. The drug is being developed for asthma, COPD, and atopic dermatitis (eczema). The study did not treat any disease but focused on finding the right dose and checking for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking Union Hospital
Beijing, Beijing Municipality, 100000, China
Conditions
Explore the condition pages connected to this study.